Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.
Grinsztejn B, De Castro N, Arnold V, Veloso VG, Morgado M, Pilotto JH, Brites C, Madruga JV, Barcellos NT, Santos BR, Vorsatz C, Fagard C, Santini-Oliveira M, Patey O, Delaugerre C, Chêne G, Molina JM; ANRS 12 180 Reflate TB study group. Grinsztejn B, et al. Among authors: veloso vg. Lancet Infect Dis. 2014 Jun;14(6):459-67. doi: 10.1016/S1473-3099(14)70711-X. Epub 2014 Apr 9. Lancet Infect Dis. 2014. PMID: 24726095 Clinical Trial.
HIV-1 controllers exhibit an enhanced antiretroviral innate state characterised by overexpression of p21 and MCPIP1 and silencing of ERVK-6 RNA expression.
de Azevedo SSD, Ribeiro-Alves M, Côrtes FH, Delatorre E, Hoagland B, Villela LM, Grinsztejn B, Veloso VG, Morgado MG, Souza TML, Bello G. de Azevedo SSD, et al. Among authors: veloso vg. Mem Inst Oswaldo Cruz. 2024 Sep 16;119:e240071. doi: 10.1590/0074-02760240071. eCollection 2024. Mem Inst Oswaldo Cruz. 2024. PMID: 39292108 Free PMC article.
Association of Current and Long-Term Estradiol Use with Carotid Intima Media Thickness Among Transgender Women: A Cross-Sectional Study.
Ferreira ACG, Moreira RC, Coelho LE, Jalil EM, Bensenor I, Friedman RK, Monteiro L, Eksterman LF, Moreira RI, Cardoso SW, Veloso VG, Chor D, Grinsztejn B, Pacheco AG. Ferreira ACG, et al. Among authors: veloso vg. Transgend Health. 2024 Dec 16;9(6):492-500. doi: 10.1089/trgh.2022.0062. eCollection 2024 Dec. Transgend Health. 2024. PMID: 39735374
Higher levels of plasmatic saturated fatty acid were significantly associated with liver fibrosis in HIV mono-infection: A case-control study.
Almeida CF, Arantes Ferreira Peres W, Silva PSD, Santos de Aguiar Cardoso C, de Andrade MM, Castro-Alves J, de Souza Borges Quintana M, Araujo MC, Fraga KYD, Cormack JA, Moreira RI, Cardoso SW, Veloso VG, Grinsztejn B, Brito PD, Perazzo H. Almeida CF, et al. Among authors: veloso vg. Metabol Open. 2024 Nov 29;24:100334. doi: 10.1016/j.metop.2024.100334. eCollection 2024 Dec. Metabol Open. 2024. PMID: 39717737 Free PMC article.
Impact of COVID-19 Pandemic on HIV Testing, Recent Infections, and Annualized Incidence Among Cisgender Men Who Have Sex With Men and Transgender Women in Brazil.
Jalil CM, Teixeira SLM, Coutinho C, Nazer SC, Carvalheira E, Hoagland B, Cardoso SW, Luz PM, Veloso VG, Grinsztejn B, Jalil EM, Torres TS. Jalil CM, et al. Among authors: veloso vg. J Acquir Immune Defic Syndr. 2025 Jan 1;98(1):12-19. doi: 10.1097/QAI.0000000000003531. Epub 2024 Dec 5. J Acquir Immune Defic Syndr. 2025. PMID: 39642281 Free PMC article.
Young men who have sex with men and digital technologies for HIV prevention and care: qualitative findings from the conectad@s study.
Castanheira D, Pereira CR, Jalil CM, Novaes D, Peixoto E, Fernandez NM, Neto EC, Bezerra DRB, Alves AS, Jalil EM, Veloso VG, Mc Farland W, Wilson EC, Grinsztejn B, Torres TS. Castanheira D, et al. Among authors: veloso vg. Cult Health Sex. 2024 Dec 3:1-16. doi: 10.1080/13691058.2024.2428329. Online ahead of print. Cult Health Sex. 2024. PMID: 39628042 Free article.
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.
Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, Van Dromme I, Van Roey GA, Kenny A, Huang Y, Carone M, McDermott AB, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Lu Y, Yu C, Juraska M, Hejazi NS, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Bekker LG, Gaur AH, Veloso VG, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Vandebosch A, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Follmann D, Koup RA, Donis RO, Gilbert PB; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; United States Government (USG)/CoVPN Biostatistics Team. Carpp LN, et al. Among authors: veloso vg. Nat Commun. 2024 Nov 12;15(1):9785. doi: 10.1038/s41467-024-53727-y. Nat Commun. 2024. PMID: 39532861 Free PMC article. Clinical Trial.
330 results